BURBANK, Calif., Aug. 16, 2006 (PRIMEZONE) -- Imaging3, Inc. (OTCBB:IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, offers insights into the image-guided surgery market, and lays out the benefits that The Dominion can provide to surgeons in this rapidly advancing surgical sector.
Image-guided is the term used to describe any surgical procedure where the surgeon employs imaging technology to indirectly visualize the anatomy of the patient. Such technologies include fluoroscopy, endoscopy, ultrasound, and other procedures. Image guided surgery, in most cases, is used in Minimally Invasive Surgery (MIS). MIS offers multiple benefits to the patient, including less trauma and pain, more rapid recovery times and shorter hospital stays. "Any technological advance in image guidance that improves and/or broadens the use of MIS is good for patients, makes surgeons more productive and improves the economics of the institutions that provide patient care," said Imaging3's CEO, Dean Janes.
Today, image guidance is performed with two-dimensional imaging technologies such as x-ray, ultrasound, and endoscopy. In these types of procedures, the surgeon is at a disadvantage with 2D technologies because they limit the surgeon's knowledge of the individual patient's anatomy due to the limited view that they provide. In order to complete a procedure, the surgeon must reorient the patient, the imaging device, the operating table or themselves - often multiple times - during the operation wasting valuable time and effort. In recent years technologies have come to market with the intent of overcoming this 2D shortcoming through a 3D solution.
However, current 3D technology as it applies to image guidance is, at best, an incremental improvement over 2D due to the loss of accuracy between the time the 3D image is taken and when the surgery is performed. These images are taken hours or days before the surgery is performed. At the time of surgery, the real-time images taken with x-ray or ultrasound, for example, are superimposed over a 3D image taken previously, thereby giving the doctor a clearer map of the patient's body, yet these images are still many hours or days old.
According to Mr. Janes, "The Dominion, being a real-time 3D imaging system, eliminates this gap in image capture time and provides the surgeon with a high resolution, easily reoriented real-time image of the patient in three-dimensions. The future standard in image guided surgery will be set by The Dominion."
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com for more information.
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.